LifeMD (LifeMD) LT-Debt-to-Total-Asset : 0.31 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is LifeMD LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. LifeMD's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.31.

LifeMD's long-term debt to total assets ratio increased from Dec. 2022 (0.02) to Dec. 2023 (0.31). It may suggest that LifeMD is progressively becoming more dependent on debt to grow their business.

LifeMD LT-Debt-to-Total-Asset Historical Data

The historical data trend for LifeMD's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LifeMD LT-Debt-to-Total-Asset Chart

LifeMD Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.01

0.02

0.31

LifeMD Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.02	0.41	0.39	0.47	0.31

LifeMD LT-Debt-to-Total-Asset Calculation

LifeMD's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	18.002	/	58.481
	=	0.31

LifeMD's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )	/	Total Assets (Q: Dec. 2023 )
	=	18.002	/	58.481
	=	0.31

LifeMD (NAS:LFMD) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

LifeMD LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of LifeMD's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

LifeMD (LifeMD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » LifeMD Inc (NAS:LFMD) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

236 Fifth Avenue, Suite 400, Fourth Floor, New York, NY, USA, 10001

Website

https://www.lifemd.com

LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.

Executives

Bertrand Velge	director	BARNHOUSE FARM, BARNHOUSE LANE BROOKLAND, ROMNEY MARSH, KENT X0 TN299TR
William J Febbo	director, other: Consultant	600 CALIFORNIA ST., 9TH FLOOR, SAN FRANCISCO CA 94108
Nicholas P Alvarez	officer: Chief Acquisition Officer	C/O LIFEMD, INC., 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Eric Harold Yecies	officer: CCO and General Counsel	C/O LIFEMD, INC., 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Brad Michael Roberts	officer: Chief Operating Officer	300 CHAFFORD COURT, SIMPSONVILLE SC 29681
Justin Schreiber	director, 10 percent owner, officer: President, Immudyne PR	236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Stefan Galluppi	director, officer: Chief Operating Officer	C/O LIFEMD, INC, 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Joan Larovere	director	C/O LIFEMD, 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Jessica Friedeman	officer: Chief Marketing Officer	C/O LIFEMD, 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Kathleen E Walsh	director	C/O LIFEMD, INC., 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Piyush Jindal	director	C/O LIFEMD, INC., 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Joseph Ditrolio	director	C/O LIFEMD, INC., 236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Maria E. Stan	officer: Principal Accounting Officer	236 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Dennis Wijnker	officer: Chief Technology Officer	536 FIFTH AVENUE, SUITE 400, NEW YORK NY 10001
Naveen Bhatia	director	823 GREENTREE RD, PACIFIC PALISADES CA 90272